通过使用高度血清性癌症球体和有机物来评估碳烯和PARP抑制剂组合疗效

Emily J Tomas1,2, Jennifer Davis1, Yudith Ramos Valdes1

  • 1Cancer Research Laboratory Program, the Mary and John Knight Translational Ovarian Cancer Research Unit, Verspeeten Family Cancer Centre, London, Canada.

Cancer biology & therapy
|January 11, 2026
PubMed
概括

多 (ADP-ribose) 聚合酶抑制剂 (PARPis) 通过向DNA修复缺陷,在治疗高度血清癌 (HGSC) 方面表现有前途. 虽然一线卡博普拉丁仍然是最佳的,但PARPis在精选的HGSC病例中在化疗前使用时可能会带来好处.

相关概念视频

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...